Insiders · Profile

Faulkingham Dell

SVP, CCO at Akebia Therapeutics. Filing since 1 Jun 2020. CIK 0001776024

Company
Date
Role
Action
Shares
Amount
Of holding
1 Mar 2022
SVP, CCO
Sold, plan not stated
6,705
$14.55K
3.7%
28 Feb 2022
SVP, CCO
Sold, plan not stated
6,479
$13.96K
4.7%
1 Apr 2021
SVP, CCO
Sold, plan not stated
952
$3.24K
0.7%
1 Mar 2021
CCO
Sold, plan not stated
6,749
$22.92K
5.0%
1 Jun 2020
CCO
Sold, plan not stated
6,426
$74.41K
8.0%
5 decisions on file.